[NEWS] Welcome aboard Morgan and Fanny!

We are pleased to welcome Morgan Cabigliera, as Head of the Sales & Marketing Business Unit and Fanny Doistau, as Clinical Business Unit Director, as part of the Biofortis team. 

Morgan has a dual background in molecular biology and business. He has more than 20 years of experience in business development in operational and strategic positions in biotech and research institutes. Also, to complete his strong experience, he has been founder of a biotech and food supplement company. 

For Biofortis, he will be a real asset to our business team and his experience in the field has made him familiar with the expectations of our clients, which is a real plus in order to continually improve our services for our customers. 

—  

With more than 15 years’ experience in Pharm Industry & Start-Up, Fanny has developed a great understanding of the challenges involved in R&D, especially in Clinical Development. 

Prior to joining Biofortis, Fanny was responsible for bringing to market Medical Devices, conducted the development of Carivalan (European Marketing Authorization in Nov. 2016), ran major international clinical studies for Valdoxan in late phase & post-registration. Prior to joining Servier, she worked in R&D for Biomerieux. Pharmacist Doctor, Fanny is also an Engineer from “Les Mines”. 

 

Welcome aboard Morgan and Fanny 👏 

[EVENT] – Biofortis will be present at PHARMABIOTICS 2024 

March 12/13/14th, 2024in Lille, France For this 2024 edition, Biofortis will be present during the Pharmabiotic Research Institute (PRI)'s annual conference in LILLE, France, 12/13/14 March 2024.  ...

Perform a user experience study under expert control

What is a user experience study? As a clinical research expert, Biofortis can also conduct other types of studies, namely user experience studies. If you have a product to promote (functional...

Biofortis will be present at PROBIOTA 2024 – Supporter level sponsor

Feb. 7th to 9th, 2024in Milan, ITALYCome and meet us at PROBIOTA in Milan, Italy.Probiota 2024, the leading Microbiome and must attend industry event will take place in the design capital of the...

[EVENT] Biofortis will be present at FIE

Nov. 28th to 30th, 2023in Frankfurt, GERMANYCome and meet us at Food Ingredients Europe (FIE) in Frankfurt, Germany.Fi Europe is the world's largest gathering of F&B ingredient buyers and...

[PRESS RELEASE] Biofortis strengthens its service offerings with the acquisition of analyze & realize

We are excited to announce that Biofortis, a leading European premium CRO has completed the acquisition of analyze & realize GmbH.    Based in Berlin, with more than 20 years’ experience in...

[EVENT] Biofortis will be present at NUTREVENT – SILVER SPONSOR 

October 17th & 18th 2023in Rennes, FRANCECome and meet us at NutrEvent in Rennes, France.As the European leading partnering event, NutrEvent is dedicated to innovation in Food, Human and Animal...

[NEWS] ACCELERATE YOUR ASSAYS

In a continuous improvement of our performance and analytical capabilities that's complements Biofortis Central lab, our expert staff members have worked to implement a new machine: LUMINEX LX-200. ...

[EVENT] Biofortis will be present at Outsourcing In Clinical Trials Europe 2023

May 3rd and 4th, 2023in Barcelona, SpainCome and meet us at the Outsourcing In Clinical Trials (OCT) Europe 2023 in Barcelona; Spain.   This event will provide participants with practical take-away...

[EVENT] Biofortis will be present at Vitafoods Europe 2023

May 9th to 11th, 2023in Geneva, SwitzerlandFor this 2023 edition, Vitafoods Europe 2023 will take a hybrid format: we will be present both virtual and in person, in Geneva, Switzerland. Vitafoods...

[EVENT] – Biofortis will be present at PHARMABIOTICS 2023

March 21th and 22th, 2023in Lyon, FranceFor this 2023 edition, Biofortis will be present during the Pharmabiotic Research Institute (PRI)'s annual conference in Lyon, France, 21/22 March 2023....